Harri Sihto

6.4k total citations
80 papers, 3.8k citations indexed

About

Harri Sihto is a scholar working on Oncology, Aerospace Engineering and Molecular Biology. According to data from OpenAlex, Harri Sihto has authored 80 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 23 papers in Aerospace Engineering and 22 papers in Molecular Biology. Recurrent topics in Harri Sihto's work include Polyomavirus and related diseases (26 papers), Antenna Design and Analysis (23 papers) and Full-Duplex Wireless Communications (22 papers). Harri Sihto is often cited by papers focused on Polyomavirus and related diseases (26 papers), Antenna Design and Analysis (23 papers) and Full-Duplex Wireless Communications (22 papers). Harri Sihto collaborates with scholars based in Finland, Sweden and United States. Harri Sihto's co-authors include Heikki Joensuu, Nina N. Nupponen, Virve Koljonen, Tom Böhling, Heli Kukko, Risto Sankila, Jorma Isola, Olli Tynninen, Jeanne M. Meis‐Kindblom and Johanna C. Andersson‐Assarsson and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Harri Sihto

74 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harri Sihto Finland 33 1.8k 1.0k 965 804 708 80 3.8k
Sheryl R. Tripp United States 29 1.0k 0.6× 864 0.9× 640 0.7× 86 0.1× 70 0.1× 65 2.6k
Weng‐Onn Lui Sweden 33 543 0.3× 2.2k 2.2× 403 0.4× 107 0.1× 75 0.1× 86 3.5k
Darrell R. Borger United States 35 1.7k 1.0× 1.7k 1.6× 1.2k 1.2× 41 0.1× 74 0.1× 86 4.1k
Zeynep Eroglu United States 26 2.8k 1.6× 1.2k 1.2× 557 0.6× 17 0.0× 97 0.1× 124 3.7k
Amod A. Sarnaik United States 34 3.0k 1.7× 1.6k 1.6× 365 0.4× 13 0.0× 121 0.2× 129 4.3k
Antje Sucker Germany 42 3.9k 2.2× 3.3k 3.3× 658 0.7× 37 0.0× 48 0.1× 101 6.8k
Ethan S. Sokol United States 25 1.5k 0.9× 1.1k 1.0× 568 0.6× 15 0.0× 66 0.1× 103 2.7k
Nina N. Nupponen Finland 35 999 0.6× 2.2k 2.2× 1.4k 1.5× 553 0.7× 14 0.0× 64 4.5k
Shumpei Ishikawa Japan 37 1.1k 0.6× 2.1k 2.0× 624 0.6× 73 0.1× 24 0.0× 126 4.5k
Pankaj Vats United States 18 1.1k 0.6× 821 0.8× 785 0.8× 5 0.0× 178 0.3× 47 2.2k

Countries citing papers authored by Harri Sihto

Since Specialization
Citations

This map shows the geographic impact of Harri Sihto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harri Sihto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harri Sihto more than expected).

Fields of papers citing papers by Harri Sihto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harri Sihto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harri Sihto. The network helps show where Harri Sihto may publish in the future.

Co-authorship network of co-authors of Harri Sihto

This figure shows the co-authorship network connecting the top 25 collaborators of Harri Sihto. A scholar is included among the top collaborators of Harri Sihto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harri Sihto. Harri Sihto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Almusa, Henrikki, et al.. (2025). Whole-exome sequencing identifies distinct genomic aberrations in eccrine porocarcinomas and poromas. Orphanet Journal of Rare Diseases. 20(1). 70–70.
2.
Joensuu, Heikki, Eva Wardelmann, Mikael Eriksson, et al.. (2023). KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial. Clinical Cancer Research. 29(17). 3313–3319. 13 indexed citations
3.
Moens, Ugo, John Inge Johnsen, Virve Koljonen, et al.. (2022). The Merkel Cell Polyomavirus T-Antigens and IL-33/ST2-IL1RAcP Axis: Possible Role in Merkel Cell Carcinoma. International Journal of Molecular Sciences. 23(7). 3702–3702. 3 indexed citations
4.
Böhling, Tom, et al.. (2021). ALK is frequently phosphorylated in Merkel cell carcinoma and associates with longer survival. PLoS ONE. 16(5). e0252099–e0252099. 5 indexed citations
5.
Joncour, Vadim Le, Maija Hyvönen, Minna Holopainen, et al.. (2019). Vulnerability of invasive glioblastoma cells to lysosomal membrane destabilization. EMBO Molecular Medicine. 11(6). 42 indexed citations
6.
Gebreyohannes, Yemarshet K., Agnieszka Woźniak, Olli Tynninen, et al.. (2018). Anagrelide for Gastrointestinal Stromal Tumor. Clinical Cancer Research. 25(5). 1676–1687. 19 indexed citations
7.
Louhimo, Riku, Bhagwan Yadav, Astrid Murumägi, et al.. (2018). Drug-Sensitivity Screening and Genomic Characterization of 45 HPV-Negative Head and Neck Carcinoma Cell Lines for Novel Biomarkers of Drug Efficacy. Molecular Cancer Therapeutics. 17(9). 2060–2071. 32 indexed citations
8.
Ihle, Michaela A., Sebastian Huss, Wolfgang Hartmann, et al.. (2018). Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment. PLoS ONE. 13(2). e0193048–e0193048. 18 indexed citations
9.
Wirtz, Ralph M., Harri Sihto, Jorma Isola, et al.. (2016). Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry. Breast Cancer Research and Treatment. 157(3). 437–446. 28 indexed citations
10.
Joensuu, Heikki, Mikael Eriksson, Kirsten Sundby Hall, et al.. (2015). Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial. Journal of Clinical Oncology. 34(3). 244–250. 149 indexed citations
11.
Hyvönen, Maija, Juulia Enbäck, Tuulia Huhtala, et al.. (2014). Novel Target for Peptide-Based Imaging and Treatment of Brain Tumors. Molecular Cancer Therapeutics. 13(4). 996–1007. 44 indexed citations
12.
Arjonen, Antti, Riina Kaukonen, Elina Mattila, et al.. (2014). Mutant p53–associated myosin-X upregulation promotes breast cancer invasion and metastasis. Journal of Clinical Investigation. 124(3). 1069–1082. 134 indexed citations
13.
Laine, Anni, Harri Sihto, Christophé Côme, et al.. (2013). Senescence Sensitivity of Breast Cancer Cells Is Defined by Positive Feedback Loop between CIP2A and E2F1. Cancer Discovery. 3(2). 182–197. 101 indexed citations
14.
Sihto, Harri, Tom Böhling, Heli Kavola, et al.. (2012). Tumor Infiltrating Immune Cells and Outcome of Merkel Cell Carcinoma: A Population-Based Study. Clinical Cancer Research. 18(10). 2872–2881. 113 indexed citations
15.
Sihto, Harri, Heli Kukko, Virve Koljonen, et al.. (2011). Merkel Cell Polyomavirus Infection, Large T Antigen, Retinoblastoma Protein and Outcome in Merkel Cell Carcinoma. Clinical Cancer Research. 17(14). 4806–4813. 142 indexed citations
16.
Rivinoja, Antti, Johan Lundin, Maija Hyvönen, et al.. (2011). An Extensive Tumor Array Analysis Supports Tumor Suppressive Role for Nucleophosmin in Breast Cancer. American Journal Of Pathology. 179(2). 1004–1014. 27 indexed citations
17.
Puputti, Marjut, Olli Tynninen, Marko Salmi, et al.. (2009). Expression of KIT Receptor Tyrosine Kinase in Endothelial Cells of Juvenile Brain Tumors. Brain Pathology. 20(4). 763–770. 16 indexed citations
18.
Sihto, Harri, Heli Kukko, Virve Koljonen, et al.. (2009). Clinical Factors Associated With Merkel Cell Polyomavirus Infection in Merkel Cell Carcinoma. JNCI Journal of the National Cancer Institute. 101(13). 938–945. 227 indexed citations
19.
Sihto, Harri, Johan Lundin, Terho Lehtimäki, et al.. (2008). Molecular Subtypes of Breast Cancers Detected in Mammography Screening and Outside of Screening. Clinical Cancer Research. 14(13). 4103–4110. 90 indexed citations
20.
Lassus, Heini, Harri Sihto, Arto Leminen, et al.. (2006). Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma. Journal of Molecular Medicine. 84(8). 671–681. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sheryl R. Tripp Breakdown of academic impact, for papers by Weng‐Onn Lui Breakdown of academic impact, for papers by Darrell R. Borger Breakdown of academic impact, for papers by Zeynep Eroglu Breakdown of academic impact, for papers by Amod A. Sarnaik Breakdown of academic impact, for papers by Antje Sucker Breakdown of academic impact, for papers by Ethan S. Sokol Breakdown of academic impact, for papers by Nina N. Nupponen Breakdown of academic impact, for papers by Shumpei Ishikawa Breakdown of academic impact, for papers by Pankaj Vats
Rankless by CCL
2026